- Home
- CNDT vs GOSS Comparison
CNDT vs GOSS Comparison
Compare CNDT & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNDT
- GOSS
- Stock Information
- Founded
- CNDT 2016
- GOSS 2015
- Country
- CNDT United States
- GOSS United States
- Employees
- CNDT N/A
- GOSS N/A
- Industry
- CNDT Business Services
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- CNDT Consumer Discretionary
- GOSS Health Care
- Exchange
- CNDT Nasdaq
- GOSS Nasdaq
- Market Cap
- CNDT 393.4M
- GOSS 347.8M
- IPO Year
- CNDT N/A
- GOSS 2019
- Fundamental
- Price
- CNDT $2.78
- GOSS $2.47
- Analyst Decision
- CNDT
- GOSS Strong Buy
- Analyst Count
- CNDT 0
- GOSS 4
- Target Price
- CNDT N/A
- GOSS $8.50
- AVG Volume (30 Days)
- CNDT 1.1M
- GOSS 3.1M
- Earning Date
- CNDT 08-06-2025
- GOSS 08-05-2025
- Dividend Yield
- CNDT N/A
- GOSS N/A
- EPS Growth
- CNDT N/A
- GOSS N/A
- EPS
- CNDT 0.06
- GOSS N/A
- Revenue
- CNDT $3,112,000,000.00
- GOSS $40,237,000.00
- Revenue This Year
- CNDT N/A
- GOSS N/A
- Revenue Next Year
- CNDT $3.08
- GOSS $30.65
- P/E Ratio
- CNDT $45.22
- GOSS N/A
- Revenue Growth
- CNDT N/A
- GOSS N/A
- 52 Week Low
- CNDT $1.90
- GOSS $0.66
- 52 Week High
- CNDT $4.90
- GOSS $2.65
- Technical
- Relative Strength Index (RSI)
- CNDT 57.62
- GOSS 68.08
- Support Level
- CNDT $2.74
- GOSS $2.38
- Resistance Level
- CNDT $2.94
- GOSS $2.65
- Average True Range (ATR)
- CNDT 0.12
- GOSS 0.15
- MACD
- CNDT 0.03
- GOSS 0.03
- Stochastic Oscillator
- CNDT 69.52
- GOSS 76.67
About CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments namely Commercial Industries which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas of which the majority of revenue is generated in the United States.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.